A detailed history of Itau Unibanco Holding S.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 777 shares of EW stock, worth $58,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares
777
Previous 20,787 96.26%
Holding current value
$58,127
Previous $1.92 Million 97.34%
% of portfolio
0.0%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$59.7 - $93.78 $1.19 Million - $1.88 Million
-20,010 Reduced 96.26%
777 $51,000
Q2 2024

Aug 13, 2024

BUY
$84.3 - $94.31 $1.75 Million - $1.96 Million
20,787 New
20,787 $1.92 Million
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $3,949 - $4,976
64 Added 7.62%
904 $68,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $277 - $373
-4 Reduced 0.47%
840 $58,000
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $244 - $282
-3 Reduced 0.35%
844 $79,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $222 - $253
-3 Reduced 0.35%
847 $70,000
Q4 2022

Feb 09, 2023

BUY
$68.3 - $87.44 $28,754 - $36,812
421 Added 98.14%
850 $63,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $17,627 - $22,960
-214 Reduced 33.28%
429 $35,000
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $531 - $653
-5 Reduced 0.77%
643 $84,000
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $23,669 - $28,232
230 Added 55.02%
648 $73,000
Q2 2021

Aug 17, 2021

BUY
$83.84 - $104.76 $35,045 - $43,789
418 New
418 $43,000
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $13,574 - $20,979
-259 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $18,570 - $21,261
259 New
259 $60,000
Q3 2018

Nov 13, 2018

SELL
$45.7 - $58.03 $6,946 - $8,820
-152 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $6,452 - $7,797
152 New
152 $22,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.